摘要
背景:我们之前报道过,喹诺烷类天然产物aloperine及其类似物在低μM浓度下可以抑制流感病毒和/或HIV-1。 目的:进一步优化aloperine抗流感病毒活性。 方法:对aloperine母核的N12部位进行结构修饰。采用常规化学合成方法得到抗病毒活性更高的衍生物。利用基于MT4细胞的HIV-1复制实验和MDCK细胞的抗流感病毒感染实验分别测定了合成化合物的抗HIV和抗流感病毒活性。 结果:Aloperine衍生物可分为三种活性组:仅具有抗HIV活性、仅具有抗流感病毒活性或对两种病毒均有活性。优化的抗流感活性Aloperine往往失去抗HIV -1活性,反之亦然。化合物19抑制流感病毒PR8复制的IC50为0.091 μM,分别是aloperine和aloperine衍生物3的160倍和60倍。 结论:数据表明,aloperine是一种特殊的可以被修饰成一种选择性抗病毒的化合物,对抗流感病毒或HIV-1的效力显著提高。
关键词: Aloperine,privileged scaffold,A型流感病毒,HIV-1,喹啉衍生物,HIV-1抑制剂。
Current Medicinal Chemistry
Title:Design and Synthesis of Quinolizidine Derivatives as Influenza Virus and HIV-1 Inhibitors
Volume: 28 Issue: 24
关键词: Aloperine,privileged scaffold,A型流感病毒,HIV-1,喹啉衍生物,HIV-1抑制剂。
摘要:
Background: We have previously reported that a quinolizidine natural product, aloperine, and its analogs can inhibit influenza virus and/or HIV-1 at low μM concentrations.
Objective: The main goal of this study was to further optimize aloperine for improved anti-influenza virus activity.
Methods: Structural modifications have been focused on the N12 position of aloperine scaffold. Conventional chemical synthesis was used to obtain derivatives with improved antiviral activities. The anti-HIV and anti-influenza virus activities of the synthesized compounds were determined using an MT4 cell-based HIV-1 replication assay and an anti- influenza virus infection of MDCK cell assay, respectively.
Results: Aloperine derivatives can be classified into three activity groups: those that exhibit anti-HIV activity only, anti–influenza virus only, or activity against both viruses. Aloperine optimized for potent anti-influenza activity often lost anti-HIV-1 activity, and vice versa. Compound 19 inhibited influenza virus PR8 replication with an IC50 of 0.091 μM, which is approximately 160- and 60-fold more potent than aloperine and the previously reported aloperine derivative compound 3, respectively.
Conclusion: The data suggest that aloperine is a privileged scaffold that can be modified to become a selective antiviral compound with markedly improved potency against influenza virus or HIV-1.
Export Options
About this article
Cite this article as:
Design and Synthesis of Quinolizidine Derivatives as Influenza Virus and HIV-1 Inhibitors, Current Medicinal Chemistry 2021; 28 (24) . https://dx.doi.org/10.2174/0929867328666201229121802
DOI https://dx.doi.org/10.2174/0929867328666201229121802 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Development of Coumarin Derivatives as Potential Antiplasmodial and Antimalarial Agents
Current Topics in Medicinal Chemistry Adenosine in the Inflamed Gut: A Janus Faced Compound
Current Medicinal Chemistry Current Medicinal Insights on Synthetic Small Molecules and Natural Origin Products as PD-1/PD-L1 Inhibitors
Current Topics in Medicinal Chemistry Interactions of Phenothiazines with Lipid Bilayer and their Role in Multidrug Resistance Reversal
Current Drug Targets Inhibition of Quorum Sensing in Staphylococcus spp.
Current Pharmaceutical Design Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands
Current Medicinal Chemistry Antimycobacterial Agents: Synthesis and Biological Evaluation of Novel 4-(Substituted-phenyl)-6-methyl-2-oxo-N-(pyridin-2-yl)-1,2,3,4-tetrahydropyrimidine- 5-carboxamide Derivatives by Using One-pot Multicomponent Method
Letters in Drug Design & Discovery Antibacterial Activity of Thioetherhydroxyethylsulfonamide Derivatives
Medicinal Chemistry Computational Models for Predicting Interactions with Cytochrome p450 Enzyme
Current Topics in Medicinal Chemistry Theoretical and Practical Considerations in Virtual Screening: A Beaten Field?
Current Medicinal Chemistry Synthesis of Metronidazole Derivatives Containing Pyridine Ring and Anticancer Activity
Letters in Organic Chemistry Properties of Ethnomedicinal Plants and Their Bioactive Compounds: Possible Use for COVID-19 Prevention and Treatment
Current Pharmaceutical Design A Genomic Approach to Investigate Neuronal Apoptosis
Current Alzheimer Research Neuroprotective Activities of Marine Natural Products from Marine Sponges
Current Medicinal Chemistry Small Molecule Aurora Kinases Inhibitors
Current Medicinal Chemistry Bacterial Lipoprotein Biosynthetic Pathway as a Potential Target for Structure-based Design of Antibacterial Agents
Current Medicinal Chemistry Is Treat-to-target in Lupus Nephritis Realistic in Clinical Practice?
Current Rheumatology Reviews Editorial [Hot Topic: Methods for the Successful Application of Chemogenomics to GPCR Drug Design (Guest Editors: Stephen L. Garland & David E. Gloriam)]
Current Topics in Medicinal Chemistry Molecular Topology and Other Promiscuity Determinants as Predictors of Therapeutic Class - A Theoretical Framework to Guide Drug Repositioning?
Current Topics in Medicinal Chemistry Subject Index to Volume 1
Letters in Drug Design & Discovery